18F-labeled proteins

Current Pharmaceutical Biotechnology

Volumn 11, Issue 6, 2010, Pages 572-580

  Wu, Zhanhong ^a   Kandeel, Fouad ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

18F; 18F Labeled proteins; Amine reactive prosthetic groups; Carboxylic acid reactive prosthetic groups; Positron emission tomography (PET); Thiol reactive prosthetic groups

Indexed keywords

AVIDIN; BENZALDEHYDE DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBRINOGEN; FLUORINE 18; FLUOROACETIC ACID; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; INSULIN; ISOTHIOCYANIC ACID; LIPOCORTIN 5; LOW DENSITY LIPOPROTEIN; PROPIONIC ACID; RADIOPHARMACEUTICAL AGENT; TRANSFERRIN; UROKINASE; DIAGNOSTIC AGENT; FLUORINE; PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; CELL ADHESION; CELL GROWTH; CELL MIGRATION; CELL SURVIVAL; CHEMICAL LABELING; CONJUGATION; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOTOPE LABELING; MONITORING; PHOTOAFFINITY LABELING; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CHEMISTRY; METHODOLOGY; MOLECULAR IMAGING; SYNTHESIS;

FLUORINE RADIOISOTOPES; HUMANS; ISOTOPE LABELING; MOLECULAR IMAGING; POSITRON-EMISSION TOMOGRAPHY; PROTEINS; RADIOPHARMACEUTICALS;

EID: 78649333871     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920110792246564     Document Type: Review

References (60)

1. Dewanjee, M.K.; Haider, N.; Narula, J. Imaging with radiolabeled antisense oligonucleotides for the detection of intracellular messenger RNA and cardiovascular disease. J. Nucl. Cardiol. 1999, 6. 345-356.
2. Maecke, H.R. Radiolabeled peptides in nuclear oncology: influence of peptide structure and labeling strategy on pharmacology. Ernst Schering Res. Found Workshop. 2005, 49, 43-72.
3. Kilbourn, M.R.; Dence, C.S.; Welch, M.J.; Mathias, C.J. Fluorine-18 labeling of proteins. J. Nucl. Med. 1987, 28. 462-470.
4. Willuda, J.; Honegger, A.; Waibel, R.; Schubiger, P.A.; Stahel, R.; Zangemeister-Wittke, U.; Pluckthun, A. High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment. Cancer Res. 1999, 59. 5758-5767.
5. Kwekkeboom, D.; Krenning, E.P.; de Jong, M. Peptide receptor imaging and therapy. J. Nucl. Med. 2000, 41. 1704-1713.
6. 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma. Eur. J. Nucl. Med. 2000, 27. 766-777.
7. 131I-tositumomab therapy as initial treatment for follicular lymphoma. N. Engl. J. Med. 2005, 352. 441-449.
8. 99mTc-HYNIC Annexin-V imaging of tumors and its relationship to response to radiotherapy and/or chemotherapy. Q. J. Nucl. Med. Mol. Imaging. 2007, 51. 182-188.
9. 131I-labeled albumin between plasma and peripheral lymph in man. Lymphology. 1979, 12. 77-80.
10. 125I-protein A from Staphylococcus aureus. J. Immunol. 1979, 122. 1073-1079.
11. 68Ga for PET imaging of HER2 expression. J. Nucl. Med. 2009, 50. 1492-1499.
12. 11C. J. Nucl. Med. 1975, 16. 425-428.
13. 18FFluoroacetate: an agent for introducing no-carrieradded fluorine-18 into urokinase without loss of biological activity. J. Label. Compd. Radiopharm. 1982, 19. 1645-1646.
14. 18F-fluoroacylation via fluorocarboxylic acid esters. J. Label. Compd. Radiopharm., 1988, 25. 185-200.
15. 18F labelling of proteins. Nucl. Med. Biol. 1994, 21. 1005-1010.
16. 18F]fluorocarboxylic acids. Appl. Radiat. Isot. 1994, 45. 715-727.
17. Wester, H.J.; Hamacher, K.; Stocklin, G. A comparative study of N.C.A. fluorine-18 labeling of proteins via acylation and photochemical conjugation. Nucl. Med. Biol. 1996, 23. 365-372.
18. 18F]SiFA-isothiocyanate: a new highly effective radioactive labeling agent for lysine-containing proteins. Chembiochem, 2009, 10. 1321-1324.
19. 18F]fluorobenzoate. Int. J. Rad. Appl. Instrum. B. 1992, 19. 275-281.
20. Toretsky, J.; Levenson, A.; Weinberg, I.N.; Tait, J.F.; Uren, A.; Mease, R.C. Preparation of F-18 labeled annexin V: a potential PET radiopharmaceutical for imaging cell death. Nucl. Med. Biol. 2004, 31. 747-752.
21. 18F](fluoromethyl) benzoate. Appl. Radiat. Isot. 1997, 48. 169-173.
22. Aloj, L.; Lang, L.; Jagoda, E.; Neumann, R.D.; Eckelman, W.C. Evaluation of human transferrin radiolabeled with N-succinimidyl 4-[fluorine-18](fluoromethyl) benzoate. J. Nucl. Med. 1996, 37. 1408-1412.
23. Garg, P.K.; Garg, S.; Zalutsky, M.R. Fluorine-18 labeling of monoclonal antibodies and fragments with preservation of immunoreactivity. Bioconjug. Chem. 1991, 2. 44-49.
24. 18F-labeled insulin: a prosthetic group methodology for incorporation of a positron emitter into peptides and proteins. Biochemistry. 1989, 28. 4801-4806.
25. 18F. J. Label. Compd. Radiopharm. 1988, 26. 287-289.
26. Kiesewetter, D.O.; Kramer-Marek, G.; Ma, Y.; Capala, J. Radiolabeling of HER2 specific Affibody(R) molecule with F-18. J. Fluor. Chem. 2008, 129. 799-805.
27. HER2:342-Affibody molecule-a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography. Eur. J. Nucl. Med. Mol. Imaging. 2008, 35. 1008-1018.
28. 18F]fluorobenzylidene)aminooxyhexyl]maleimide. Nucl. Med. Biol. 2007, 34. 5-15.
29. 18F-labelled pyridine-based alkylating agent for high yield oligonucleotide conjugation. Appl. Radiat. Isot. 2009, 67. 1670-1675.
30. Li, X.; Link, J.M.; Stekhova, S.; Yagle, K.J.; Smith, C.; Krohn, K.A.; Tait, J.F. Site-specific labeling of annexin V with F-18 for apoptosis imaging. Bioconjug. Chem. 2008, 19. 1684-1688.
31. 18F]fluoropyridin-3-yloxy)propyl]pyrrole-2,5-dione: design, synthesis, and radiosynthesis of a new [18F]fluoropyridine-based maleimide reagent for the labeling of peptides and proteins. Bioconjug. Chem. 2005, 16. 406-420.
32. 18F-labeling of peptides and proteins. Bioconjug. Chem. 2008, 19. 1202-1210.
33. 18F]fluorobenzaldehyde via oxime chemistry. Mol. Imaging Biol. 2008, 10. 177-181.
34. 18F using a hydrazone-formation method. Bioconjug. Chem. 2005, 16. 1329-1333.
35. 18F]fluorobenzoate and its application to the labeling of a monoclonal antibody fragment. Bioconjug. Chem. 1994, 5. 352-356.
36. 18F-labelled recombinant annexin-V derivative, for identification and quantification of apoptotic cells with PET. Appl. Radiat. Isot. 2003, 58. 201-207.
37. 18F. Nat. Protoc. 2006, 1. 1655-1661.
38. 18F]fluorobenzoate using a Siemens/CTI chemistry process control unit (CPCU). Appl. Radiat. Isot. 2007, 65. 199-203.
39. 18F]SFB). J. Label. Compd. Radiopharm. 2009, 52. 327-330.
40. 18F peptide labeling: hydrazone formation with HYNIC-conjugated c(RGDyK). Nucl. Med. Biol. 2006, 33. 677-683.
41. 18F-labeled protein scaffold molecules. J. Nucl. Med. 2008, 49. 804-813.
42. 18F-labeling of the protein hormone leptin using a general two-step ligation procedure. J. Am. Chem. Soc. 2008, 130. 9106-9112.
43. Quinlan, G.J.; Martin, G.S.; Evans, T.W. Albumin: biochemical properties and therapeutic potential. Hepatology. 2005, 41. 1211-1219.
44. 99mTc annexin V. J. Nucl. Med. 1999, 40. 184-191.
45. Meers, P.; Mealy, T. Calcium-dependent annexin V binding to phospholipids: stoichiometry, specificity, and the role of negative charge. Biochemistry. 1993, 32. 11711-11721.
46. Vermes, I.; Haanen, C.; Steffens-Nakken, H.; Reutelingsperger, C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods. 1995, 184. 39-51.
47. 123I-labelled human recombinant annexin V. Biomol. Eng. 2001, 17. 51-53.
48. 99mTc EC annexin V: preliminary clinical study targeting apoptosis in breast tumors. Appl. Radiat. Isot. 2008, 66. 1175-1182.
49. 99mTc-annexin V imaging for in vivo detection of atherosclerotic lesions in porcine coronary arteries. J. Nucl. Med. 2005, 46. 1186-1193.
50. 99mTc-Hynic-Annexin V. North American Scientific. IDrugs. 2004, 7. 264-269.
51. Grierson, J.R.; Yagle, K.J.; Eary, J.F.; Tait, J.F.; Gibson, D.F.; Lewellen, B.; Link, J.M.; Krohn, K.A. Production of [F-18] fluoroannexin for imaging apoptosis with PET. Bioconjug. Chem. 2004, 15. 373-379.
52. 18F-labelled annexin V: a PET tracer for apoptosis imaging. Eur. J. Nucl. Med. Mol. Imaging. 2004, 31. 469-474.
53. 18F-annexin V as a PET imaging agent in an animal model of apoptosis. J. Nucl. Med. 2005, 46. 658-666.
54. Menard, S.; Pupa, S.M.; Campiglio, M.; Tagliabue, E. Biologic and therapeutic role of HER2 in cancer. Oncogene. 2003, 22. 6570-6578.
55. Ross, R. Atherosclerosis--an inflammatory disease. N. Engl. J. Med. 1999, 340. 115-126.
56. Heinecke, J.W. Oxidized amino acids: culprits in human atherosclerosis and indicators of oxidative stress. Free Radic. Biol. Med. 2002, 32. 1090-1101.
57. Pietzsch, J.; Lattke, P.; Julius, U. Oxidation of apolipoprotein B-100 in circulating LDL is related to LDL residence time. In vivo insights from stable-isotope studies. Arterioscler Thromb Vasc. Biol. 2000, 20. E63-67.
58. Pietzsch, J.; Bergmann, R. Measurement of 5-hydroxy-2-aminovaleric acid as a specific marker of metal catalysed oxidation of proline and arginine residues of low density lipoprotein apolipoprotein B-100 in human atherosclerotic lesions. J. Clin. Pathol. 2003, 56. 622-623.
59. Pietzsch, J.; Bergmann, R.; Wuest, F.; Pawelke, B.; Hultsch, C.; van den Hoff, J. Catabolism of native and oxidized low density lipoproteins: in vivo insights from small animal positron emission tomography studies. Amino Acids. 2005, 29. 389-404.
60. Pietzsch, J.; Bergmann, R.; Rode, K.; Hultsch, C.; Pawelke, B.; Wuest, F.; van den Hoff, J. Fluorine-18 radiolabeling of lowdensity lipoproteins: a potential approach for characterization and differentiation of metabolism of native and oxidized low-density lipoproteins in vivo. Nuclic Med. Biol. 2004, 31. 1043-1050.